MSME (Udyam registered) Ministry of MSME
- Category
- Small (2024-25)
- Udyam number
- UDYAM-WB-10-0023230
Delbruk Lifescience Private Limited - events and entertainment in Kolkata, West Bengal, India. FY 2026 financials & compliance.
Revenue · FY 2025
₹9.41 Cr
▲ 30% YoY
Net profit · FY 2025
₹6.78 Lakh
Net margin 0.7%
EBITDA · FY 2025
₹32.39 Lakh
EBITDA margin 3.4%
Authorised capital
₹25 Lakh
Registered with MCA
Paid-up capital
₹25 Lakh
Issued & subscribed
Open charges
₹2.75 Cr
Secured borrowings
Company age
6 yrs
Est. 2020
Employees · EPFO
65
Provident fund records
About Delbruk Lifescience Private Limited
Data last updated:
Delbruk Lifescience Private Limited is a private limited company based in Kolkata, West Bengal, India. It operates in the event planning and management segment of the events and entertainment sector. It was incorporated on 23 April 2020 and has been in existence for over 6 years.
The company is registered with the Registrar of Companies (ROC), Kolkata, under CIN U33301WB2020PTC237106. Its GSTIN is 19AAHCD7306E1ZQ (West Bengal). The company holds 2 GST registrations, all of them active.
The company has an authorised share capital of ₹25 Lakh and a paid-up capital of ₹25 Lakh. It is led by directors including Anjana Mukherjee and Bhumika.
Its last annual general meeting (AGM) was held on 30 September 2025, and its latest financial statements are for the year ended 31 March 2025. The registered office is at East Rabindra Pally Ncp Netaji Road Thana Titagarh, Kolkata, West Bengal, India – 700122.
As per the financials filed for FY 2025, the company reported a revenue of ₹9.41 Cr, a growth of 30% compared to the previous year. For the same year it recorded a net profit of ₹6.78 Lakh (net margin 0.7%) and EBITDA of ₹32.39 Lakh (EBITDA margin 3.4%). Revenue has grown at a compounded annual rate (CAGR) of 35% over three years.
The company has about 65 employees on its provident fund (EPFO) records.
As per MCA filings, the company has open charges of ₹2.75 Cr on record.
Delbruk Lifescience Private Limited is registered as a small enterprise under the Udyam registration framework (Reg. No. UDYAM-WB-10-0023230). For more details, the company can be reached via its website delbruklifescience.com.
Company Details of Delbruk Lifescience Private Limited
CIN U33301WB2020PTC237106
Registration Number 237106
Incorporation Date 23 April 2020
ROC Kolkata
Listing Status Unlisted
Company Status Active
Date of Last AGM 30 September 2025
Date of Balance Sheet 31 March 2025
MSME Classification Small
Udyam Registration UDYAM-WB-10-0023230
Recognitions & Rankings of Delbruk Lifescience
Contact Details
- EmailLocked
- TelephoneLocked
- Website
- Social Media
- Registered AddressEast Rabindra Pally Ncp Netaji Road Thana Titagarh, Kolkata, West Bengal, India – 700122
- IndustryEvents and Entertainment, Event Planning & Management
Comprehensive company report
Delbruk Lifescience Private Limited - one report that includes everything
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
- One PDF report, delivered after checkout
₹799 ₹999 20% off excluding 18% GST
Secure checkout · GST invoice included
Business Activity of Delbruk Lifescience Private Limited
The main business activity of Delbruk Lifescience is hospital and medical care. In detail, this covers other hospital and medical care activities.
| Main Activity Group Code | Description of Main Activity | Business Activity Code | Description of Business Activity | Turnover Percentage |
|---|---|---|---|---|
| Q | Hospital and Medical Care | Q6 | Other Hospital and Medical Care Activities | Locked |
Premium access
Business activity turnover details
Turnover share and past changes in activity are in the company report.
- Turnover contribution
- Historical classifications
- Filing-level activity changes
Verified entity values are shown only after access is granted.
Financials of Delbruk Lifescience Private Limited FY 2025 filings available
Delbruk Lifescience Private Limited reported revenue of ₹9.41 Cr (up 30% YoY) for FY 2025.
Revenue · FY 2025
₹9.41 Cr ▲ 30%
Net profit · FY 2025
₹6.78 Lakh margin 0.7%
EBITDA · FY 2025
₹32.39 Lakh margin 3.4%
Compounded Annual Growth Rate (CAGR) of Delbruk Lifescience Private Limited
Revenue CAGR growth
1 year
▲ 30%
3 years · compounded
▲ 35%
EBITDA CAGR growth
1 year
▲ 78%
3 years · compounded
▲ 88%
Revenue has grown at a compounded annual rate (CAGR) of 35% over three years, including 30% growth in the latest year. EBITDA rose 78% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary of Delbruk Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | •••• | •••• | •••• | •••• | •••• |
| Other Income | •••• | •••• | •••• | •••• | •••• |
| Total Revenue | •••• | •••• | •••• | •••• | •••• |
| Cost of Materials Consumed | •••• | •••• | •••• | •••• | •••• |
| Employee Benefit Expense | •••• | •••• | •••• | •••• | •••• |
| Finance Costs | •••• | •••• | •••• | •••• | •••• |
| Depreciation and Amortisation | •••• | •••• | •••• | •••• | •••• |
| Other Expenses | •••• | •••• | •••• | •••• | •••• |
| Total Expenses | •••• | •••• | •••• | •••• | •••• |
| EBITDA | ₹32.39 Lakh | •••• | •••• | •••• | •••• |
| Profit Before Tax | •••• | •••• | •••• | •••• | •••• |
| Tax Expense | •••• | •••• | •••• | •••• | •••• |
| Net Profit (PAT) | ₹6.78 Lakh | •••• | •••• | •••• | •••• |
| Balance Sheet | |||||
| Share Capital | •••• | •••• | •••• | •••• | •••• |
| Reserves and Surplus | •••• | •••• | •••• | •••• | •••• |
| Net Worth (Total Equity) | •••• | •••• | •••• | •••• | •••• |
| Long-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Short-term Borrowings | •••• | •••• | •••• | •••• | •••• |
| Trade Payables | •••• | •••• | •••• | •••• | •••• |
| Total Liabilities | •••• | •••• | •••• | •••• | •••• |
| Fixed Assets | •••• | •••• | •••• | •••• | •••• |
| Investments | •••• | •••• | •••• | •••• | •••• |
| Inventories | •••• | •••• | •••• | •••• | •••• |
| Trade Receivables | •••• | •••• | •••• | •••• | •••• |
| Cash and Bank Balance | •••• | •••• | •••• | •••• | •••• |
| Total Assets | •••• | •••• | •••• | •••• | •••• |
Financial Ratios of Delbruk Lifescience Private Limited
| Metrics | FY 2024-25 | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 3.4% | •••• | •••• | •••• | •••• |
| Net Profit Margin | 0.7% | •••• | •••• | •••• | •••• |
| Return on Equity (ROE) | •••• | •••• | •••• | •••• | •••• |
| Return on Capital Employed (ROCE) | •••• | •••• | •••• | •••• | •••• |
| Return on Assets (ROA) | •••• | •••• | •••• | •••• | •••• |
| Liquidity and Debt | |||||
| Current Ratio | •••• | •••• | •••• | •••• | •••• |
| Quick Ratio | •••• | •••• | •••• | •••• | •••• |
| Debt-to-Equity Ratio | •••• | •••• | •••• | •••• | •••• |
| Interest Coverage Ratio | •••• | •••• | •••• | •••• | •••• |
| Efficiency and Growth | |||||
| Asset Turnover | •••• | •••• | •••• | •••• | •••• |
| Receivable Days | •••• | •••• | •••• | •••• | •••• |
| Payable Days | •••• | •••• | •••• | •••• | •••• |
| Inventory Days | •••• | •••• | •••• | •••• | •••• |
| Revenue Growth | •••• | •••• | •••• | •••• | •••• |
| Net Profit Growth | •••• | •••• | •••• | •••• | •••• |
Paid data: the figures shown as dots are available after purchase of the company report. Figures as filed with the MCA in Form AOC-4. The full year-wise statements and ratios of Delbruk Lifescience are in the company report.
Premium access
Financial statements from FY 2021
Earlier years and trend charts are in the company report.
- Income statements
- Balance sheets
- Cash-flow statements
- Ratios and benchmarks
Verified entity values are shown only after access is granted.
Board of Directors of Delbruk Lifescience Private Limited
Delbruk Lifescience has 4 directors on record. No former directors are listed.
Current Directors
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Anjana Mukherjee | Director | 23 Apr 2020 | 6 Years 5 Months | Current |
| Bhumika Also directs: Delbruk Pharmaceuticals Private Limited | Director | 21 Apr 2021 | 5 Years 6 Months | Current |
| Simmi Mukherjee | Director | 23 Apr 2020 | 6 Years 5 Months | Current |
| Ramanuj Mukherjee Also directs: Delbruk Pharmaceuticals Private Limited | Director | 23 Apr 2020 | 6 Years 5 Months | Current |
Peer Comparison of Delbruk Lifescience Private Limited
Delbruk Lifescience Private Limited is compared with the companies closest to it by revenue in the Pharma industry (Formulations). Net profit, margin and employee counts of each company are in the company report.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Guru Mahima Agros Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 1.0% | •••• | Bholath, Punjab, India |
| Avacare India Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 51.0% | •••• | Mumbai, Maharashtra, India |
| RPS Biotech Private Limited | ₹9.43 Cr (FY 2024) | •••• | •••• | -16.0% | •••• | Satara, Maharashtra, India |
| Medisphere Life Sciences Private Limited | ₹9.43 Cr (FY 2025) | •••• | •••• | 12.0% | •••• | Hyderabad, Telangana, India |
| Procare Pharma Private Limited | ₹9.42 Cr (FY 2025) | •••• | •••• | -21.0% | •••• | New Delhi, Delhi, India |
| Delbruk Lifescience Private Limited this company | ₹9.41 Cr (FY 2025) | •••• | •••• | 30.0% | •••• | Kolkata, West Bengal, India |
| Sumangalam Formulations Private Limited | ₹9.39 Cr (FY 2025) | •••• | •••• | 61.0% | •••• | Vilayat, Gujarat, India |
| Zevemed Healthcare Private Limited | ₹9.39 Cr (FY 2024) | •••• | •••• | 117.0% | •••• | Secunderabad, Telangana, India |
| Organon Homoeo Laboratory Pvt Ltd | ₹9.39 Cr (FY 2025) | •••• | •••• | 10.0% | •••• | Kolkata, West Bengal, India |
| Emmchak Formulations Private Limited | ₹9.37 Cr (FY 2025) | •••• | •••• | 11.0% | •••• | Tiruchirappalli, Tamil Nadu, India |
| Unicorn Pharmachem Private Limited | ₹9.36 Cr (FY 2024) | •••• | •••• | -48.0% | •••• | Mumbai, Maharashtra, India |
Peers are the five companies nearest above and the five nearest below Delbruk Lifescience by revenue in the Pharma industry (Formulations), from the latest filed financials of each company. Net profit, margin and employee counts of each peer are in the company report.
Auditor Details of Delbruk Lifescience Private Limited
Delbruk Lifescience Private Limited is audited by MOHAN AGRAWAL& ASSOCIATES for the financial year 2022.
| Name | Status | Appointment Date | Cessation Date |
|---|---|---|---|
| MOHAN AGRAWAL& ASSOCIATES | Locked | Locked | Locked |
Premium access
Complete auditor history
Appointment and cessation dates and past auditor changes are in the company report.
- Appointment status
- Appointment dates
- Cessation dates
- Auditor changes
Verified entity values are shown only after access is granted.
Ownership and Shareholding of Delbruk Lifescience Private Limited
Premium access
Shareholding and ownership data
Promoter, institutional, public and beneficial ownership figures are in the company report.
- Ownership categories
- Historical changes
- Group structure
- FII and DII holdings
Verified entity values are shown only after access is granted.
Charges & Borrowings of Delbruk Lifescience Private Limited
Open charges
₹2.75 Cr
Satisfied charges
None
Breakdown by lending institutions
Latest charge details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 06 Feb 2024 | Axis Bank Limited | ₹2.75 Cr | Open |
Total charge records: 1 View all charges
Employees and EPFO Compliance at Delbruk Lifescience Private Limited
Delbruk Lifescience Private Limited has a workforce of 65 employees as of Apr 03, 2024.
Employee count
65
Active EPFO establishments
1
Employee growth
6.56%
Premium access
Employee and EPFO history
Monthly headcount, contribution history and filing status are in the company report.
- Monthly headcount
- PF contributions
- ECR filing status
- Establishment history
Verified entity values are shown only after access is granted.
Recent Activity on Delbruk Lifescience Private Limited
Delbruk Lifescience Private Limited has 4 board changes on record since 2020: 4 appointments. The latest: Bhumika was appointed as Director on 21 Apr 2021.
Charges
A charge with Axis Bank Limited of Rs. 275.00 Lakh registered on 06 Feb 2024 with Charge ID 100861707 was modified on 23 Jan 2026.
AGM
Delbruk Lifescience Private Limited last Annual general meeting of members was held on 30 Sep 2025 as per latest MCA records.
Filing
Delbruk Lifescience Private Limited has filed its annual Financial statements for the year ended 31 Mar 2025 with Roc Kolkata I.
Charges
A charge with Axis Bank Limited amounted to Rs. 275.00 Lakh with Charge ID 100861707 was registered on 06 Feb 2024.
Appointed
Bhumika was appointed as Director.
Appointed
Anjana Mukherjee was appointed as Director.
Appointed
Ramanuj Mukherjee was appointed as Director.
Appointed
Simmi Mukherjee was appointed as Director.
Incorporation
23 Apr 2020
Delbruk Lifescience Private Limited was registered on 23 Apr 2020 with Roc Kolkata I & aged 6 years 6 months as per MCA records.
Credit Ratings, Litigation & Regulatory Alerts for Delbruk Lifescience Private Limited
Premium access
Credit ratings, litigation, and regulatory alerts
Credit ratings, court records and regulatory alerts are in the company report.
- Rating history
- Court and tribunal cases
- Regulatory alerts
- Director-linked violations
Verified entity values are shown only after access is granted.
MSME Payment Delays by Delbruk Lifescience Private Limited
Premium access
MSME payment history
Amounts due to small suppliers, the reasons given and MSME-1 filings are in the company report.
- Outstanding amounts
- Delay periods and reasons
- MSME-1 filing history
- Vendor payment signals
Verified entity values are shown only after access is granted.
Subsidiaries & Group Companies of Delbruk Lifescience Private Limited
Premium access
Corporate group structure
Parent, subsidiary, associate and joint venture records with holdings are in the company report.
- Parent company
- Subsidiaries and ownership
- Associates and joint ventures
- Entity investments
Verified entity values are shown only after access is granted.
GST Compliance of Delbruk Lifescience Private Limited
Delbruk Lifescience has 2 GST registrations: 2 active.
Total GSTINs
2
Active
2
| GSTIN | State | Status | Registered on |
|---|---|---|---|
| 19AAHCD7306E1ZQ | West Bengal | Active | 09 May 2020 |
| 07AAHCD7306E1ZV | Delhi | Active | 30 Apr 2021 |
Premium access
GST registrations and filing compliance
State-wise GST registrations, return filing status and HSN or SAC codes are in the company report.
- GSTIN registrations
- State-wise filing status
- HSN and SAC details
- Tax jurisdiction records
Verified entity values are shown only after access is granted.
MCA Filings & Documents of Delbruk Lifescience Private Limited
Premium access
MCA filings and documents
Filed forms, annual returns, financial statements and charge filings with their dates are in the company report.
- Incorporation documents
- Annual returns and statements
- Charge filings
- Complete filing index
Verified entity values are shown only after access is granted.
Frequently Asked Questions about Delbruk Lifescience Private Limited
Delbruk Lifescience is an active private limited company based in Kolkata, West Bengal, India. The company works in event planning and management, within the events and entertainment industry. It was incorporated on 23 April 2020 (6+ years old) and is registered under CIN U33301WB2020PTC237106.
Delbruk Lifescience reported revenue of ₹9.41 Cr for FY 2025 (up 30% YoY).
Delbruk Lifescience has 4 current directors:
- Anjana Mukherjee - Director
- Bhumika - Director
- Simmi Mukherjee - Director
- Ramanuj Mukherjee - Director
Delbruk Lifescience reported a net profit of ₹6.78 Lakh (net margin 0.7%) and EBITDA of ₹32.39 Lakh (EBITDA margin 3.4%) for FY 2025, as per its filed financial statements.
The compounded annual growth rate (CAGR) of the revenue of Delbruk Lifescience is 35% over three years. In the latest year (FY 2025) revenue rose 30%. CAGR is the steady yearly rate that links the first and the last year.
The GSTIN of Delbruk Lifescience is 19AAHCD7306E1ZQ, registered in West Bengal. The company has 2 GST registrations in all, of which 2 are active. Other active GSTINs include 07AAHCD7306E1ZV (Delhi).
The CIN (Corporate Identification Number) of Delbruk Lifescience is U33301WB2020PTC237106. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Delbruk Lifescience was incorporated on 23 April 2020, making it 6+ years old. It is registered with the Registrar of Companies, Kolkata.
The peers of Delbruk Lifescience by revenue are Guru Mahima Agros Private Limited, Avacare India Private Limited, RPS Biotech Private Limited, Medisphere Life Sciences Private Limited, Procare Pharma Private Limited and 5 more, all in the Pharma industry (Formulations).
Bhumika was appointed as Director on 21 Apr 2021. Anjana Mukherjee was appointed as Director on 23 Apr 2020. Ramanuj Mukherjee was appointed as Director on 23 Apr 2020. Delbruk Lifescience has 4 board changes on record in total.
Yes, Delbruk Lifescience is registered as a small enterprise under Udyam registration (number: UDYAM-WB-10-0023230).